SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq:LJPC) reported a net loss for the three months ended December 31, 2007 of $14.4 million, or $0.36 per share (on 39.6 million weighted-average shares), compared to a net loss of $10.7 million, or $0.33 per share (on 32.7 million weighted-average shares), for the same period in 2006. The Company reported a net loss for the twelve months ended December 31, 2007 of $53.1 million, or $1.40 per share (on 37.8 million weighted-average shares), compared to a net loss of $39.4 million, or $1.21 per share (on 32.6 million weighted-average shares), for the same period in 2006.
